Colgate-Palmolive: JPMorgan maintains a Neutral on Colgate-Palmolive (India) with a Target Price of ₹2,250, citing a positive FY27 outlook driven by balanced volume-price growth, premiumisation in oral care (Total, Whitening, PerioGard), manageable price hikes, improving urban demand, stable rural demand, resilient category trends, and stable-to-improving margins despite higher brand investments.

 10 Jun 2026 08:53 AM

Colgate-Palmolive: JPMorgan maintains a Neutral on Colgate-Palmolive (India) with a Target Price of ₹2,250, citing a positive FY27 outlook driven by balanced volume-price growth, premiumisation in oral care (Total, Whitening, PerioGard), manageable price hikes, improving urban demand, stable rural demand, resilient category trends, and stable-to-improving margins despite higher brand investments.

Colgate: HSBC maintains a Hold on Colgate with a Target Price of ₹2150, citing Q4 sales growth ahead of estimates driven equally by volume and value, positive traction in premium products and premiumization as a long-term growth driver, while seeing limited change in overall growth trajectory despite a slight EBITDA estimate upgrade.

 25 May 2026 08:59 AM

Colgate: HSBC maintains a Hold on Colgate with a Target Price of ₹2150, citing Q4 sales growth ahead of estimates driven equally by volume and value, positive traction in premium products and premiumization as a long-term growth driver, while seeing limited change in overall growth trajectory despite a slight EBITDA estimate upgrade.

Colgate: Nomura upgrades Colgate to Buy with a Target Price of ₹2500, citing normalization in core portfolio performance, strong premiumization trends, revival in volume growth to 4.5% in Q4, and expectations of near double-digit revenue growth in FY27 driven by mid-single-digit volume and pricing growth without demand backlash.

 25 May 2026 09:00 AM

Colgate: Nomura upgrades Colgate to Buy with a Target Price of ₹2500, citing normalization in core portfolio performance, strong premiumization trends, revival in volume growth to 4.5% in Q4, and expectations of near double-digit revenue growth in FY27 driven by mid-single-digit volume and pricing growth without demand backlash.

Colgate: Jefferies maintains a Buy on Colgate with a Target Price of ₹2600, citing resilient core oral care demand, expectations of double-digit EPS growth in FY27 aided by a favorable base after three weak years, and potential for renewed investor interest despite inconsistent revenue growth trends.

 25 May 2026 09:00 AM

Colgate: Jefferies maintains a Buy on Colgate with a Target Price of ₹2600, citing resilient core oral care demand, expectations of double-digit EPS growth in FY27 aided by a favorable base after three weak years, and potential for renewed investor interest despite inconsistent revenue growth trends.

Colgate: Citi maintains a Sell on Colgate with a Target Price of ₹2050, citing gradual recovery in growth driven by premiumisation, improving urban demand and favorable base, but expects only steady volume recovery amid rising margin pressure from higher ad spends, GST headwinds and intense competition.

 25 May 2026 09:00 AM

Colgate: Citi maintains a Sell on Colgate with a Target Price of ₹2050, citing gradual recovery in growth driven by premiumisation, improving urban demand and favorable base, but expects only steady volume recovery amid rising margin pressure from higher ad spends, GST headwinds and intense competition.

Colgate: Kotak Institutional Equities maintains a Reduce on Colgate with a Target Price of ₹2025, citing strong 9% revenue growth driven by balanced volume and pricing gains, but warning of near-term EBITDA margin pressure from gross margin decline, higher ad spends and the inverted duty structure impact.

 25 May 2026 09:00 AM

Colgate: Kotak Institutional Equities maintains a Reduce on Colgate with a Target Price of ₹2025, citing strong 9% revenue growth driven by balanced volume and pricing gains, but warning of near-term EBITDA margin pressure from gross margin decline, higher ad spends and the inverted duty structure impact.

COLGATE PALMOLIVE (INDIA): Q4 SL NET PROFIT 3.53B RUPEES VS 3.6B (YOY) || Q4 REVENUE 15.8B RUPEES VS 14.5B (YOY)

 22 May 2026 04:54 PM

COLGATE PALMOLIVE (INDIA): Q4 SL NET PROFIT 3.53B RUPEES VS 3.6B (YOY) || Q4 REVENUE 15.8B RUPEES VS 14.5B (YOY)

COLGATE PALMOLIVE (INDIA): Q4 EBITDA 4.93B RUPEES VS 4.98B (YOY) || Q4 EBITDA MARGIN 31.15% VS 34.3% (YOY)

 22 May 2026 04:54 PM

COLGATE PALMOLIVE (INDIA): Q4 EBITDA 4.93B RUPEES VS 4.98B (YOY) || Q4 EBITDA MARGIN 31.15% VS 34.3% (YOY)

COLGATE PALMOLIVE (INDIA): FINAL DIVIDEND OF 24 RUPEES PER SHARE

 22 May 2026 04:54 PM

COLGATE PALMOLIVE (INDIA): FINAL DIVIDEND OF 24 RUPEES PER SHARE